References
- 1Mensah GA, Fuster V, Murray CJL, Roth GA, Mensah GA, Abate YH, et al. Global Burden of Cardiovascular Diseases and Risks, 1990–2022. J Am Coll Cardiol. 2023 Dec; 82(25):2350–473.
- 2Muka T, Imo D, Jaspers L, Colpani V, Chaker L, van der Lee SJ, et al. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. Eur J Epidemiol. 2015 Apr 18; 30(4):251–77. DOI: 10.1007/s10654-014-9984-2
- 3Minja NW, Nakagaayi D, Aliku T, Zhang W, Ssinabulya I, Nabaale J, et al. Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward. Front Cardiovasc Med. 2022 Nov 10; 9. DOI: 10.3389/fcvm.2022.1008335
- 4Murphy A, Palafox B, O’Donnell O, Stuckler D, Perel P, AlHabib KF, et al. Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study. Lancet Glob Health. 2018 Mar; 6(3):e292–301. DOI: 10.1016/S2214-109X(18)30031-7
- 5Filbey L, Zhu JW, D’Angelo F, Thabane L, Khan MS, Lewis E, et al. Improving representativeness in trials: a call to action from the Global Cardiovascular Clinical Trialists Forum. Eur Heart J. 2023 Mar 14; 44(11):921–30. DOI: 10.1093/eurheartj/ehac810
- 6Grobbee DE, Pellicia A. Secondary prevention of cardiovascular disease: Unmet medical need, implementation and innovation. Eur J Prev Cardiol. 2017 Jun 16; 24(3_suppl):5–7. DOI: 10.1177/2047487317709369
- 7Huffman MD, Labarthe DR, Yusuf S. Global Cardiovascular Research Training for Implementation Science, Health Systems Research, and Health Policy Research. J Am Coll Cardiol. 2015 Apr; 65(13):1371–2. DOI: 10.1016/j.jacc.2015.02.023
- 8Iwelunmor J, Ogedegbe G, Dulli L, Aifah A, Nwaozuru U, Obiezu-Umeh C, et al. Organizational readiness to implement task-strengthening strategy for hypertension management among people living with HIV in Nigeria. Implement Sci Commun. 2023 May 4; 4(1):47. DOI: 10.1186/s43058-023-00425-3
- 9Collins D, Laatikainen T, Farrington J. Implementing essential interventions for cardiovascular disease risk management in primary healthcare: lessons from Eastern Europe and Central Asia. BMJ Glob Health. 2020 Feb 12; 5(2):
e002111 . DOI: 10.1136/bmjgh-2019-002111 - 10Weber MB, Baumann AA, Rakhra A, Akwanalo C, Gladys Amaning Adjei K, Andesia J, et al. Global implementation research capacity building to address cardiovascular disease: An assessment of efforts in eight countries. PLOS Global Public Health. 2023 Sep 14; 3(9):
e0002237 . DOI: 10.1371/journal.pgph.0002237 - 11Tudor Hart J. The Inverse Care Law. The Lancet. 1971 Feb; 297(7696):405–12. DOI: 10.1016/S0140-6736(71)92410-X
- 12Cookson R, Doran T, Asaria M, Gupta I, Mujica FP. The inverse care law re-examined: A global perspective. The Lancet. 2021 Feb; 397(10276):828–38. DOI: 10.1016/S0140-6736(21)00243-9
- 13Capewell S, Graham H. Will Cardiovascular Disease Prevention Widen Health Inequalities? PLoS Med. 2010 Aug 24; 7(8):
e1000320 . DOI: 10.1371/journal.pmed.1000320 - 14Fuster V, Kelly BB, Vedanthan R. Promoting Global Cardiovascular Health. Circulation. 2011 Apr 19; 123(15):1671–8. DOI: 10.1161/CIRCULATIONAHA.110.009522
- 15World Heart Federation. Emerging Leaders Programme [Internet]. 2024 [cited 2014 Oct 1]. Available from:
https://world-heart-federation.org/emerging-leaders/ . - 16Mensah GA. Training in Cardiovascular Epidemiology and Prevention. Glob Heart. 2018; 13(4). DOI: 10.1016/j.gheart.2018.09.526
- 17International Society for Cardiovascular Epidemiology and Prevention. Ten Day International Teaching Seminar on Cardiovascular Epidemiology and Prevention [Internet]. 2024 [cited 2014 Oct 1]. Available from:
https://iscep.info/seminars . - 18Harvard TH Chan School of Public Health. The Bernard Lown Scholars in Cardiovascular Health Program [Internet]. 2024 [cited 2014 Oct 1]. Available from:
https://www.hsph.harvard.edu/lownscholars/ .